CE vs CHE · rev $10.28B vs P/E 24, rev $2.43B
Celanese Corporation (CE) versus Chemed Corp (CHE) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
CE currently screens at market cap $5.92B. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Not investment advice. Open the CE and CHE stock pages for the full models.
Not investment advice.